Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001641172-25-025122
Filing Date
2025-08-22
Accepted
2025-08-21 18:50:37
Documents
9

Document Format Files

Seq Description Document Type Size
1 POS AM formposam.htm POS AM 1625148
2 EX-23.1 ex23-1.htm EX-23.1 4602
3 EX-23.3 ex23-3.htm EX-23.3 5299
4 EX-23.4 ex23-4.htm EX-23.4 4526
5 GRAPHIC ex_23-1.jpg GRAPHIC 7086
6 GRAPHIC formdrs_001.jpg GRAPHIC 15567
7 GRAPHIC forms-1fin_001.jpg GRAPHIC 40816
8 GRAPHIC forms-1fin_002.jpg GRAPHIC 2471
9 GRAPHIC fin_001.jpg GRAPHIC 58637
  Complete submission text file 0001641172-25-025122.txt   1812985
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-286754 | Film No.: 251241936
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)